Search Results 711-720 of 21594 for Inhibition
Examples include studying the tight binding and inhibition of proteins, exploring the ability to trigger new cell responses, enhancing drug delivery, and ...
... inhibitors and ARB's is allowed within the 3 months prior to randomization. Pharmacological Therapy (as appropriate):. Angiotensin converting enzyme (ACE) ...
... inhibitor. These medicines are injected under the skin or through an intravenous line. Another option is a Janus kinase (JAK) inhibitor. JAK inhibitors are ...
difficile are twice as likely to get it again. Other known risk factors include proton-pump inhibitors for gastric reflux, immunosuppression, and long hospital ...
This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...
So new guidelines have come out in recent years suggesting that some of the tried-and-true quadruple therapies which include a proton pump inhibitor ...
... inhibitors and inhibitors of receptors such as EGFR and IGFR1. Studies of CI1033, an EGFR tyrosine kinase inhibitor, combined with topoisomerase I ...
In working to identify small-molecule drug candidates, the lab recently discovered that inhibition ... inhibitors for the treatment of Alzheimer's disease and FTD ...
... inhibitors). ELIGIBILITY CRITERIA - PHASE I (ARMS A, B, C):. Patient may be enrolled with a prior allogeneic hematopoietic stem cell transplant (HSCT) but ...
... inhibitor (such as bivalirudin, argatroban, dabigatran or lepirudin). Received Factor Xa inhibitors (such as Fondaparinaux, apixaban or rivaroxaban) within ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.